Lipid- and polymer-based nanostructures for cancer theranostics

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Nanotheranostics merges in vivo diagnosis and therapy via nano-sized carriers.
• It enhances nanomedicine by visualizing drug circulation and biodistribution.
• Clinical applications include real-time monitoring for personalized cancer treatment.

Purpose of the Study:

• To review recent advancements in nanotheranostics for cancer research.
• To focus on lipid- and polymer-based nanotheranostic formulations.
• To discuss the integration of therapeutic agents with imaging modalities.

Main Methods:

• Review of recent literature on nanotheranostics.
• Focus on lipid- and polymer-based nanocarriers.
• Discussion of combined therapeutic and imaging agents.

Main Results:

• Nanotheranostics offers combined diagnosis and therapy in one nano-carrier.
• It allows real-time monitoring, reducing dosing errors and personalizing treatment.
• Integration of imaging agents (MRI, radionuclide, fluorescence) with therapeutics is advancing.

Conclusions:

• Nanotheranostics presents significant opportunities for cancer diagnosis and therapy.
• Lipid- and polymer-based formulations are key areas of development.
• The synergy of therapeutic and diagnostic functions in nanomedicine is crucial for future cancer care.